Bright Minds Biosciences DRUG Estimates

NASDAQ DRUG
$49.74 -1.92 (-3.72%)
At close: Sep 29, 2026 · 4:00 PM EDT
Analyst Estimates

Bright Minds Biosciences Inc. Quarterly Revenue Estimates

Periods 14
Next Period Q3 22
Consensus 0.00

Analysts expect Bright Minds Biosciences Inc. to report revenue of 0.00 for Q3 22, against a range of 0.00 to 0.00. The most recent reported quarter, Q3 26, came in at 0.00.

Metric Q3 22Q4 22Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27
Reported (Actual) --0.000.000.000.000.000.000.000.00----
High Estimate 0.000.00-0.000.000.000.000.000.000.000.000.000.000.00
Low Estimate 0.000.00-0.000.000.000.000.000.000.000.000.000.000.00
Consensus Estimate 0.000.00-0.000.000.000.000.000.000.000.000.000.000.00
Analyst Estimates

Bright Minds Biosciences Inc. Quarterly Earnings Per Share (EPS) Estimates

Periods 12
Next Period Q4 26
Consensus -1.04

Analysts expect Bright Minds Biosciences Inc. to report earnings per share of -1.04 for Q4 26, against a range of -1.10 to -0.98. The most recent reported quarter, Q3 26, came in at -0.17, a 86.7% beat against the -1.28 consensus.

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27
Reported (Actual) -0.120.01-0.30-0.54-0.43-0.71-0.79-0.17----
High Estimate -0.41-0.02-0.32-0.52-0.55-0.78-0.82-1.22-0.98-1.20-1.32-1.75
Low Estimate -0.49-0.02-0.34-0.62-0.63-0.88-0.90-1.34-1.10-1.28-1.60-1.91
Consensus Estimate -0.45-0.02-0.33-0.57-0.59-0.83-0.86-1.28-1.04-1.24-1.46-1.83

Bright Minds Biosciences Inc. Estimates API

Pull Wall Street consensus for Bright Minds Biosciences Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=DRUG&mode=revenue&api_key=YOUR_API_KEY